UTI Inc (179900) - Cash Flow Conversion Efficiency
Based on the latest financial reports, UTI Inc (179900) has a cash flow conversion efficiency ratio of -0.224x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-11.36 Billion ≈ $-7.70 Million USD) by net assets (₩50.75 Billion ≈ $34.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of UTI Inc to measure how much of total assets are equity-financed.
UTI Inc - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how UTI Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 179900 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
UTI Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of UTI Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ledlink Optics
TWO:5230
|
0.045x |
|
Briacell Therapeutics Corp
NASDAQ:BCTX
|
-0.302x |
|
3S KOREA Co. Ltd
KQ:060310
|
-0.004x |
|
Broadpeak SA
PA:ALBPK
|
0.056x |
|
Grand Ocean Retail Group Ltd
TW:5907
|
0.020x |
|
SANGBO Corp
KQ:027580
|
-0.080x |
|
Arch Biopartners Inc
V:ARCH
|
0.129x |
|
Superlon Holdings Bhd
KLSE:7235
|
0.027x |
Annual Cash Flow Conversion Efficiency for UTI Inc (2015–2024)
The table below shows the annual cash flow conversion efficiency of UTI Inc from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see 179900 market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩74.53 Billion ≈ $50.51 Million |
₩-31.31 Billion ≈ $-21.22 Million |
-0.420x | +13.52% |
| 2023-12-31 | ₩17.22 Billion ≈ $11.67 Million |
₩-8.36 Billion ≈ $-5.67 Million |
-0.486x | -828.82% |
| 2022-12-31 | ₩47.26 Billion ≈ $32.03 Million |
₩3.15 Billion ≈ $2.14 Million |
0.067x | -29.86% |
| 2021-12-31 | ₩60.64 Billion ≈ $41.09 Million |
₩5.76 Billion ≈ $3.91 Million |
0.095x | +35.38% |
| 2020-12-31 | ₩58.26 Billion ≈ $39.48 Million |
₩4.09 Billion ≈ $2.77 Million |
0.070x | -65.57% |
| 2019-12-31 | ₩61.88 Billion ≈ $41.93 Million |
₩12.62 Billion ≈ $8.55 Million |
0.204x | +25.87% |
| 2018-12-31 | ₩59.55 Billion ≈ $40.35 Million |
₩9.65 Billion ≈ $6.54 Million |
0.162x | +26.46% |
| 2017-12-31 | ₩55.17 Billion ≈ $37.39 Million |
₩7.07 Billion ≈ $4.79 Million |
0.128x | -83.17% |
| 2016-12-31 | ₩18.39 Billion ≈ $12.46 Million |
₩14.01 Billion ≈ $9.49 Million |
0.761x | +363.45% |
| 2015-12-31 | ₩5.47 Billion ≈ $3.71 Million |
₩-1.58 Billion ≈ $-1.07 Million |
-0.289x | -- |
About UTI Inc
UTI Inc. engages in the research, development, manufacture, and sale of smartphone camera windows and sensor glasses in South Korea and internationally. The company offers cover glass for recognizing fingerprints, glass for IOT, 3D cover glass, flexible display cover glass, G2 TSP and AG glass for car industry; and IOT/ICT composite sensor module, smart haptic module, motor for low-powered drone,… Read more